To Register for the Comprehensive Cardiometabolic Risk Reduction Program June 1, 2008 in Seattle:
Click Here

Download Information for the Seattle Program

The Comprehensive Cardiometabolic Risk Reduction Program (CCRR) is a collaborative educational initiative sponsored by the NLA to promote enhanced standards of care for cardiometabolic risk management. The purpose of this program is to inform lipid specialists on novel ways of addressing cardiometabolic risk factors, including dyslipidemia, dysglycemia, hypertension, excess bodyweight/central adiposity, and emerging markers.

Program content will detail the evolving challenges of cardiometabolic risk management, the latest thinking on the drivers of cardiometabolic risk, key concepts in patient identification and assessment, and new strategies for treatment and patient management.

Through educational courses and ongoing support, this educational initiative will strive to foster a paradigm shift in cardiometabolic risk management by broadening treatment protocols utilized in lipid clinics throughout the United States.

Throughout 2008, the CCRR educational curriculum will be delivered regionally at 4-hour live CME courses hosted at leading lipid clinics. For those members who attend a regional course, the CCRR program will serve as a gateway to participate in an ongoing educational network and to take steps toward fulfilling the NLA's professional and practice development pathways.

For more information or to register for all other CCRR courses, visit the program website at www.CardioMetRisk.com.

Program Objectives

• Discuss the complexities of cardiometabolic risk-management in patients who are overweight or obese
• Establish criteria for the evaluation and classification of patients with cardiometabolic risk
• Reinforce the importance of lifestyle modification and provide recommendations regarding clinical interventions that may enhance the management of cardiometabolic risk
• Provide healthcare provider tools and patient education materials to facilitate cardiometabolic risk management

Course Agenda Topics (4-Hr Program)

Evolving Challenges in CM Risk Management

• Epidemic of overweight/obesity and diabetes
• Residual risk remaining with current treatments

The Drivers of Cardiometabolic Risk

• Link between central adiposity and cardiometabolic risk
• Mechanisms underlying negative effects

Patient Evaluation and Classification

• Basics of office-based obesity care
• Keys to assessing CM risk levels

Treating the Overweight/Obese Patient

• Assessment of medications that may contribute to weight gain
• Selection of medications for weight loss

Patient Management

• Managing risk with diet and exercise
• Tips for effective patient referral, clinical monitoring, and follow-up

Case Studies

• 2 case studies to help apply the program recommendations in a clinical scenario

Treatment program - Implementation

• Roles for healthcare team members
• Specific processes for patient identification and follow-up

Accreditation

CME credit provided by the National Lipid Association.

Target Audience

This activity is designed for physicians and all health care professionals who manage patients with cardiometabolic risk factors, including dyslipidemia, dysglycemia, hypertension, and excess body weight.

Commercial Support

Educational grant support is provided by Sanofi-Aventis. It is the policy of the National Lipid Association to adhere to ACCME Essential Areas, Policies, and Standards for Commercial Support to ensure fair balance, independence, objectivity, and scientific rigor in all its sponsored activities.

Core Curriculum Faculty

Louis J. Aronne, MD, FACP
Clinical Professor of Medicine
Weill Medical College of Cornell University
Adjunct Associate Professor of Clinical Medicine
Columbia University College of Physicians & Surgeons
New York, New York

Christie M. Ballantyne, MD
Professor of Medicine
Chief, Section of Atherosclerosis and Vascular Medicine
Department of Medicine
Baylor College of Medicine;
Director, Center for Cardiovascular Disease Prevention
Methodist DeBakey Heart Center
Houston, Texas

Robert H. Eckel, MD
Professor
Department of Medicine
Department of Physiology and Biophysics
University of Colorado Health Sciences Center
Director, Lipid Clinic
University of Colorado Hospital
Denver, Colorado

Peter H. Jones, MD, FACP
Associate Professor of Medicine
Section of Atherosclerosis and Lipid Research
Co-Director, Lipid Metabolism and Atherosclerosis Clinic
Baylor College of Medicine
Houston, Texas

Cathy Nonas, MS, RD, CDE
Director, Diabetes and Obesity Programs
North General Hospital;
Assistant Clinical Professor
Mt. Sinai School of Medicine
New York, New York

Thomas A. Wadden, PhD
Professor of Psychology
Department of Psychiatry
Director, Center for Weight and Eating Disorders
University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania

Anne M. Wolf, RD, MS
Instructor of Research
Department of Public Health Sciences
University of Virginia School of Medicine
Charlottesville, Virginia